Screening of potential spike glycoprotein / ACE2 dual antagonists against COVID-19 in silico molecular docking

12Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

Your institution provides access to this article.

Abstract

The novel coronavirus disease has spread rapidly and caused sustained pressure on economic and medical resources to many countries. Vaccines and effective drugs are needed to fight against the epidemic. Traditional Chinese Medicine (TCM) plays an important and effective role in the treatment of COVID-19. Therefore, the active components of TCM are potential structural basis for the discovery of antiviral drugs. Through screening by molecular docking, Oleanolic acid, Tryptanthrin, Chrysophanol and Rhein were found to have better spike protein and ACE2 inhibitory activity, which could block the invasion and recognition of SARS-CoV-2 at the same time, should be investigated as antiviral candidates.

Cite

CITATION STYLE

APA

Yu, R., & Li, P. (2022). Screening of potential spike glycoprotein / ACE2 dual antagonists against COVID-19 in silico molecular docking. Journal of Virological Methods, 301. https://doi.org/10.1016/j.jviromet.2021.114424

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free